Skip to main content

TWO SIGMA INVESTMENTS, LP

Position in FLGT — Fulgent Genetics, Inc.

CIK 1179392 NEW YORK, NY

Position in FLGT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,122,805
-$2,688,710 QoQ
Shares Held
322,189
+8.4% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 97.20660854343258.ToString("F0")% Shared 0.ToString("F0")% None 2.7933914565674187.ToString("F0")%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Derivatives in FLGT

reported options exposure · as of Dec 31, 2021
CallValue
$2,162,685
CallShares
21,500
PutValue
$2,353,806
PutShares
23,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $1,108,346,968 across 33 Diagnostics & Research names. FLGT ranks #12 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLGT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,122,805 322,189
2025-12-31 $7,811,515 297,355
2025-09-30 $3,561,940 157,608
2025-06-30 $1,863,133 93,719
2025-03-31 $897,457 53,104
2024-12-31 $1,479,114 80,082
2024-09-30 $1,799,917 82,831
2024-06-30 $435,701 22,207
2024-03-31 $206,150 9,500
2022-12-31 $628,358 21,100
2021-12-31 $2,162,685 21,500
2021-12-31 $2,353,806 23,400
2021-09-30 $2,959,355 32,900
2021-09-30 $4,794,335 53,300
2021-06-30 $3,209,604 34,800
2021-06-30 $3,513,963 38,100
2021-06-30 $461,150 5,000
2021-03-31 $850,256 8,800
2021-03-31 $821,270 8,500